Outcome of mechanical ventilation for adults with hematologic malignancy

Journal of Investigative Medicine

Volumn 44, Issue 5, 1996, Pages 254-260

  Epner, Daniel E ^a,c   White, Peter ^b   Krasnoff, Mark ^b   Khanduja, Sanjay ^b   Kimball, Kay T ^c   Knaus, William A ^d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Intratracheal intubation I bone marrow transplantation I hematologic diseases I outcome assessment

Indexed keywords

ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; FEMALE; HUMAN; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RESPIRATORY FAILURE; STATISTICS; SURVIVOR; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; APACHE; BALTIMORE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; PROGNOSIS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030168009     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Brochstein JA. Critical care issues in bone marrow transplantation. Crit Care Clin 1988;4:147-66.
2. Wingard JR, Mellits ED, Sostrin MB, Chen DY-H, Burns WH, Santos GW, Vriesendorp HM, Beschorner WE, Saral R. Interstitial pneumonitis after allogeneic bone marrow transplantation. Medicine 1988;67:175-86.
3. Wingard JR, Sostrin MB, Vriesendorp HM, Mellits ED, Santos GW, Fuller DJ, Braine HG, Yeager AM, Burns WH, Saral R. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1988;46:61-5.
4. Wingard JR, Chen DY-H, Burns WH, Fuller DJ, Braine HG, Yeager AM, Kaiser H, Burke PJ, Graham ML, Santos GW, Saral R. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 1988;71:1432-7.
5. Noble, PW. The pulmonary complications of bone marrow transplantation in adults. West J Med 1989;150:443-9.
6. Hildebrand FL, Rosenow EC III, Tazelaar, HD. Pulmonary complications of leukemia. Chest 1990;98:1233-9.
7. Crawford SW, Schwartz DA, Petersen FB, Clark JG. Mechanical ventilation after marrow transplantation. Am Rev Respir Dis 1988;137:682-7.
8. Dees A, Ligthart JL, van Putten WLJ, Planting AST, Stoter, G. Mechanical ventilation in cancer patients. Analysis of clinical data and outcome. Neth J Med 1990;37:183-8.
9. Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ. Prognosis of patients receiving intensive care for life-threatening medical complications of haematological malignancy. BMJ 1988;296:1025-9.
10. Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis 1992;145:510-4.
11. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive care unit support. Mayo Clin Proc 1992;67:117-22.
12. Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A. Intensive care, survival, and expense of treating critically ill cancer patients. JAMA 1993;269:783-6.
13. Paz HL, Crilley P, Weinar M, Brodsky I. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest 1993;104:527-31.
14. Crawford SW. Decision making in critically ill patients with hematologic malignancy. West J Med 1991;155:488-93.
15. Peters SG, Meadows JA III, Gracey DR. Outcome of respiratory failure in hematologic malignancy. Chest 1988;94:99-102.
16. Schuster DP, Marion JM. Precedents for meaningful recovery during treatment in a medical intensive care unit. Am J Med 1983;75:402-8.
17. Ludwigs UG, Baehrendtz S, Wanecek M, Matell G. Mechanical ventilation in medical and neurological diseases; 11 years of experience. J Intern Med 1991;229:117-24.
18. Torrecilla C, Cortés JL, Chamorro C, Rubio JJ, Galdos P, Dominguez de Villota E. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med 1988;14:393-98.
19. Estopa R, Marti AT, Kastanos N, Rives A, Agusti-Vidal A, Rozman C. Acute respiratory failure in severe hematologic disorders. Crit Care Med 1984;12:26-8.
20. Denardo SJ, Oye RK, Bellamy PE. Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med 1989;17:4-6.
21. Brunet F, Lanore JJ, Dhainaut JF, Dreyfus F, Vaxelaire JF, Nouira S, Giraud T, Armoganidis A, Monsallier JF. Is intensive care justified for patients with haematological malignancies? Intensive Care Med 1990;16:291-7.
22. Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ. Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med 1986;12:317-24.
23. Knaus WA, Wagner DP, Lynn J. Short-term mortality predictions for critically ill hospitalized adults: science and ethics. Science 1991;254:389-94.
24. Murphy DJ, Burrows D, Santilli S, Kemp AW, Tenner S, Kreling B, Teno J. The influence of probability of survival on patients' preferences regarding cardiopulmonary resuscitation. N Engl J Med 1994;330:545-9.
25. Jayes RL, Zimmerman JE, Wagner DP, Draper EA, Knaus WA. Do-not-resuscitate orders in intensive care units. JAMA 1993;270:2213-7.
26. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
27. Lemeshow S, Le Gall J-R. Modeling the severity of illness of ICU patients. JAMA 1994;272:1049-55.
28. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A, Harrell FE. The APACHE III prognostic system. Chest 1991;100:1619-36.
29. Wong DT, Knaus WA. Predicting outcome in critical care: the current status of APACHE prognostic scoring system. Can J Anaesth 1991;38:374-83.
30. Johnson MH, Gordon PW, Fitzgerald FT. Stratification of prognosis in granulocytopenic patients with hematologic malignancies using the APACHE - II severity of illness score. Crit Care Med 1986;14:693-7.
31. Lemeshow S, Teres D, Klar J, Avrunin JS, Gehlbach SH, Rapoport J. Mortality Probability Model (MPM II) based on an international cohort of intensive care unit patients. JAMA 1993;270:2478-86.
32. Geller RB, Burke PJ, Karp JE, Hemphrey RL, Braine HG, Tucker RW, Fox MG, Zahurak M. Morrell L, Hall KL, et al. A two-step timed sequential treatment for acute myelocytic leukemia. Blood 1989;74:1499-506.
33. Geller RB, Saral R, Piantadosi S, Zahurak M, Vogelsong GB, Wingard JR, Ambinder RF, Beschorner WB, Braine HG, Burns WH, et al. Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia. Blood 1989;73:2209-18.
34. Chalfin, DB, Carlon, GC. Age and utilization of intensive care unit resources of critically ill cancer patients. Crit Care Med 1990;18:694-8.
35. Chelluri L, Pinsky MR, Donahoe MP, Grenvik A. Long-term outcome of critically ill elderly patients requiring intensive care. JAMA 1993;269:3119-23.
36. Carlon GC. Admitting cancer patients to the intensive care unit. Crit Care Clin 1988;4:183-92.
37. Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988;109:783-8.
38. Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 1991;324:1005-11.
39. Elfenbein GJ, Siddiqui T, Rand KH, Graham-Pole J, Marcus RB, Mendenhall NP, Goedert TM, Wikle-Fisher T, Gross SA, Weiner RS. Successful strategy for prevention of cytomegalovirus interstitial pneumonia after human leukocyte antigen-identical bone marrow transplantation. Reviews of Infectious Diseases 2 (7 Suppl): 1990;S805-10.